PHAXIAM Therapeutics SA (DELISTED) (PHXM:DL)
3.10
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
PHAXIAM Therapeutics Price: 3.10 for March 11, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 11, 2024 | 3.10 | 3.10 | 3.10 | 3.10 | 0.000 |
| Mar 08, 2024 | 3.06 | 3.10 | 3.05 | 3.10 | 902.00 |
| Mar 07, 2024 | 3.01 | 3.290 | 3.01 | 3.12 | 1851.00 |
| Mar 06, 2024 | 3.01 | 3.01 | 3.01 | 3.01 | 0.000 |
| Mar 05, 2024 | 2.94 | 3.12 | 2.80 | 3.01 | 3349.00 |
| Mar 04, 2024 | 3.03 | 3.161 | 2.50 | 2.50 | 4819.00 |
| Mar 01, 2024 | 2.722 | 3.02 | 2.53 | 2.81 | 5488.00 |
| Feb 29, 2024 | 2.74 | 2.74 | 2.74 | 2.74 | 0.000 |
| Feb 28, 2024 | 2.98 | 3.10 | 2.74 | 2.74 | 1166.00 |
| Feb 27, 2024 | 2.989 | 2.989 | 2.989 | 2.989 | 0.000 |
| Feb 26, 2024 | 2.93 | 3.098 | 2.93 | 2.989 | 6193.00 |
| Feb 23, 2024 | 2.905 | 2.905 | 2.905 | 2.905 | 1415.00 |
| Feb 22, 2024 | 2.85 | 3.065 | 2.83 | 2.83 | 1322.00 |
| Feb 21, 2024 | 3.31 | 3.31 | 2.700 | 2.83 | 12295.00 |
| Feb 20, 2024 | 3.46 | 3.790 | 3.46 | 3.790 | 620.00 |
| Feb 16, 2024 | 3.70 | 3.70 | 3.70 | 3.70 | 0.000 |
| Feb 15, 2024 | 3.70 | 3.70 | 3.70 | 3.70 | 602.00 |
| Feb 14, 2024 | 3.75 | 3.75 | 3.75 | 3.75 | 0.000 |
| Feb 13, 2024 | 3.75 | 3.75 | 3.75 | 3.75 | 0.000 |
| Feb 12, 2024 | 3.75 | 3.75 | 3.75 | 3.75 | 1910.00 |
| Feb 09, 2024 | 3.99 | 3.99 | 3.99 | 3.99 | 0.000 |
| Feb 08, 2024 | 3.692 | 3.99 | 3.692 | 3.99 | 1744.00 |
| Feb 07, 2024 | 3.630 | 3.99 | 3.630 | 3.99 | 457.00 |
| Feb 06, 2024 | 4.02 | 4.02 | 4.02 | 4.02 | 0.000 |
| Feb 05, 2024 | 4.02 | 4.02 | 4.02 | 4.02 | 515.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.50
Minimum
Mar 04 2024
120.12
Maximum
Jan 19 2021
39.23
Average
42.20
Median
Oct 03 2019
Price Benchmarks
| DBV Technologies SA | 0.65 |
| Cellectis SA | 3.20 |
| Genfit SA | 3.70 |
| Innate Pharma SA | 2.545 |
| Inventiva SA | 3.45 |
Price Related Metrics
| PE Ratio | 1.031 |
| Price to Book Value | 0.4731 |
| Earnings Yield | 96.99% |